Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COTAM corticosteroid therapy in acute myocarditis with severe left ventricular dysfunction
2024-510602-90-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute myocarditis comparing Corticosteroid therapy with Placebo control (2 arms). Planned start Mar 2025; status: authorised.
02
Drugs
methylprednisoloneprednisone
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2024-510602-90-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510602-90-00.